FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts

(2019) Danijel Sikic et al.   Translational Oncology

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification

(2019) Hyeong Dong Yuk et al.   BMC CANCER

Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes

(2019) Sang Hyun Yoo et al.   UROLOGIA INTERNATIONALIS

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening

(2018) Sebastien Rinaldetti et al.   Oncotarget

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy

(2018) Michael S. Leapman et al.   EUROPEAN UROLOGY

Variants and new entities of bladder cancer

(2018) Antonio Lopez-Beltran et al.   HISTOPATHOLOGY

mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants

(2018) Markus Eckstein et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

(2017) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

(2017) Roland Seiler et al.   EUROPEAN UROLOGY

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification

(2017) Gottfrid Sjödahl et al.   JOURNAL OF PATHOLOGY

FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma

(2017) Joshua I. Warrick et al.   VIRCHOWS ARCHIV

In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival

(2017) Johannes Breyer et al.   VIRCHOWS ARCHIV

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer

(2017) Mathilde Borg Houlberg Thomsen et al.   Scientific Reports

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

(2016) Johannes Breyer et al.   UROLOGIA INTERNATIONALIS

Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta

(2015) Atiqullah Aziz et al.   WORLD JOURNAL OF UROLOGY

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

(2014) Robert S. Svatek et al.   EUROPEAN UROLOGY

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer

(2014) Woonyoung Choi et al.   Nature Reviews Urology

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

(2014) J. S. Damrauer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improving bladder cancer patient care: a pharmacoeconomic perspective

(2013) John L Gore et al.   Expert Review of Anticancer Therapy

Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?

(2012) Cristina Gazquez et al.   BJU INTERNATIONAL

A Molecular Taxonomy for Urothelial Carcinoma

(2012) G. Sjodahl et al.   CLINICAL CANCER RESEARCH

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation

(2012) David J. DeGraff et al.   PLoS One

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY